Transfusion of Blood Products is not Associated with Intensive Care Unit-Acquired Weakness when Corrected for Illness Severity

Abstract

Introduction Intensive Care Unit-acquired weakness (ICU-AW) is a common and severe complication of intensive care admission. We studied the effect of blood product transfusion (possibly a modifiable risk factor) on ICU-AW. Methods Records of blood product transfusion (red blood cell, platelet and plasma) were analyzed in a database from a prospective observational cohort study where newly admitted ICU patients who were mechanically ventilated ≥2 days were included. Manual muscle strength was measured according to the Medical Research Council (MRC) scale, when patients were awake and attentive. ICU–AW was defined as an average MRC score <4. Results Of 196 patients, 98 patients (50%) were diagnosed with ICU-AW. A significantly higher odds ratio (OR) for ICU-AW was found in patients receiving red blood cells(OR 2.85, 95% CI 1.58-5.15), plasma (OR 2.38, 95% CI 1.30–4.35) or platelet transfusion (OR 2.09, 95% CI 1.16–3.75) compared to non-transfused patients. The number of red blood cell units (OR 1.07, 95% CI 1.02-1.13) and platelet units (OR 1.24, 95% CI 1.07-1.43) were also associated with ICU-AW. However, when corrected for illness severity, these associations were no longer significant. Conclusion The association between transfusion and ICU-AW is explained by illness severity. Risk reducing strategies to prevent development of ICU-AW should focus on other possible risk factors.

Authors and Affiliations

Woodward Roger, Wieske Luuk, Juffermans Nicole, Horn Janneke

Keywords

Related Articles

Magnesium on Blockage of Nuclear Factor-B Activation at Ventilator-Induced Lung Injury: Random Trial

Rationale The mechanical ventilation may aggravate the severe acute lung injury and trigger a systemic inflammatory response. The pathophysiology evolves Biotrauma, meaning that the over distension and the cyclical openi...

Continuous Infusion Ketamine for Adjunctive Sedation in Medical Intensive Care Unit Patients: A Case Series

Ketamine has been rarely described for use in critically ill patients. We describe our institutional experience using continuous infusion ketamine for sedation. This was a retrospective chart review of patients admitted...

Anaesthetic Management of a Child with Laryngeal Papillomas

The excision of laryngeal papillomas poses a great challenge for both the anesthesiologist and the surgeon. Laser surgery offers several advantages to the surgeon and patient; i.e. microscopic precision, a bloodless oper...

Awake Retromolar Bonfils Intubation in Patient with Very Low Mouth Opening

According to the Italian Society of Anesthesiology (SIAARTI) guidelines, an awake fiberoptic intubation is the gold standard to manage a predicted difficult airway. At our institution, we are experienced in the use of th...

Fibromyalgia - Out of The Dark Tunnel

My name is Valerie Lumley, recovered fibromyalgic and author of “Curing Chronic Fibromyalgia – Choosing What Works.” The intension of my book first is to help fibromyalgia (FMS) sufferers regain their health, and secondl...

Download PDF file
  • EP ID EP618925
  • DOI -
  • Views 143
  • Downloads 0

How To Cite

Woodward Roger, Wieske Luuk, Juffermans Nicole, Horn Janneke (2015). Transfusion of Blood Products is not Associated with Intensive Care Unit-Acquired Weakness when Corrected for Illness Severity. Enliven: Journal of Anesthesiology and Critical Care Medicine, 2(8), 106-109. https://www.europub.co.uk/articles/-A-618925